GSK3B and renal cell carcinoma: Acylglycerol kinase (AGK) activates the GSK3β S9 phosphorylation site via the PI3K/AKT pathway, leading to GSK3β inactivation, β-catenin stabilization, and subsequent promotion of RCC growth and metastasis (Zhu et al., 2020).